Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.270
+0.080 (6.72%)
At close: Mar 6, 2026, 4:00 PM EST
1.280
+0.010 (0.79%)
After-hours: Mar 6, 2026, 7:56 PM EST
Akebia Therapeutics Employees
Akebia Therapeutics had 194 employees as of December 31, 2025. The number of employees increased by 13 or 7.18% compared to the previous year.
Employees
194
Change (1Y)
13
Growth (1Y)
7.18%
Revenue / Employee
$1,217,505
Profits / Employee
-$27,552
Market Cap
340.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aurora Cannabis | 1,073 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Evolus | 329 |
| Aquestive Therapeutics | 142 |
AKBA News
- 4 days ago - Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 5 days ago - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - Akebia Therapeutics, Inc. (AKBA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights - GlobeNewsWire
- 16 days ago - Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights - GlobeNewsWire
- 22 days ago - Akebia Therapeutics, Inc. (AKBA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript - Seeking Alpha
- 4 weeks ago - Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 7 weeks ago - Akebia Post-Selloff: Revenue Dynamics And Upcoming Catalysts - Seeking Alpha